Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Insider Purchase: Director at $RXO Buys 8,317 Shares

Automated

Troy A. Cooper, a director at $RXO, bought 8,317 shares of the company on 11-20-2025 for an estimated $88,243. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 3.1%. Following this trade, they now own 275,416 shares of this class of $RXO stock.

$RXO Insider Trading Activity

RXO Insider Trades

$RXO insiders have traded $RXO stock on the open market 6 times in the past 6 months. Of those trades, 5 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $RXO stock by insiders over the last 6 months:

  • JASON S. KERR (Chief Accounting Officer) sold 33,343 shares for an estimated $385,778
  • THOMAS A SZLOSEK purchased 20,308 shares for an estimated $251,209
  • ANDREW M. WILKERSON (Chief Executive Officer) has made 2 purchases buying 11,625 shares for an estimated $149,422 and 0 sales.
  • ADRIAN KINGSHOTT purchased 9,350 shares for an estimated $100,512
  • TROY A. COOPER purchased 8,317 shares for an estimated $88,243

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$RXO Hedge Fund Activity

We have seen 138 institutional investors add shares of $RXO stock to their portfolio, and 149 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$RXO Analyst Ratings

Wall Street analysts have issued reports on $RXO in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

  • Morgan Stanley issued a "Overweight" rating on 11/11/2025
  • Susquehanna issued a "Negative" rating on 11/07/2025
  • Barclays issued a "Overweight" rating on 11/07/2025
  • Truist Securities issued a "Buy" rating on 11/07/2025

To track analyst ratings and price targets for $RXO, check out Quiver Quantitative's $RXO forecast page.

$RXO Price Targets

Multiple analysts have issued price targets for $RXO recently. We have seen 8 analysts offer price targets for $RXO in the last 6 months, with a median target of $15.5.

Here are some recent targets:

  • Ravi Shanker from Morgan Stanley set a target price of $19.0 on 11/11/2025
  • Bascome Majors from Susquehanna set a target price of $10.0 on 11/07/2025
  • Brandon Oglenski from Barclays set a target price of $15.0 on 11/07/2025
  • Thomas Wadewitz from UBS set a target price of $15.0 on 11/07/2025
  • Lucas Servera from Truist Securities set a target price of $20.0 on 11/07/2025
  • J. Bruce Chan from Stifel set a target price of $17.0 on 10/10/2025
  • Jordan Alliger from Goldman Sachs set a target price of $15.0 on 10/09/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles